Amanda M. DiNofia

机构：Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia University · ORCID：0000-0002-8321-0403

发表论文 99 篇 · 总被引 2002 次 · h-index 21

代表论文

• Long-term safety of lentiviral or gammaretroviral gene-modified T cell therapies (2025 · Nature Medicine · 被引 76)
• Reinfusion of CD19 CAR T cells for relapse prevention and treatment in children with acute lymphoblastic leukemia (2024 · Blood Advances · 被引 32)
• CD22-targeted chimeric antigen receptor-modified T cells for children and adults with relapse of B-cell acute lymphoblastic leukemia after CD19-directed immunotherapy (2025 · Journal for ImmunoTherapy of Cancer · 被引 21)
• Quadriparesis and paraparesis following chimeric antigen receptor T-cell therapy in children and adolescents (2024 · Blood · 被引 21)
• Therapies and outcomes following extramedullary relapse of pediatric and young adult ALL after CD19 CAR T-cell therapy (2024 · Blood Advances · 被引 7)
• CD19 CAR T cell therapy is an effective strategy for first CNS relapse in pediatric b ALL (2025 · Blood · 被引 4)